GlassScriptPhysician profile
Joel Ragland
NPI 1386633402
$1,109.67
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $36.82 · 2021: $412 · 2022: $158 · 2023: $218 · 2024: $69.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $240.23 | 2021 | |
| Zimvie INC. | $176.19 | 2022-2023 | |
| Depuy Synthes Sales INC. | $130.87 | 2019-2024 | Conduit, Acis |
| Si-Bone, INC. | $100.38 | 2021-2022 | |
| Smoky Mountain Surgical LLC | $58.60 | 2023-2024 | |
| Nuvasive, INC. | $46.82 | 2023 | Acp |
| Providence Medical Technology, INC. | $46.61 | 2019 | |
| Nevro Corp. | $45.12 | 2023 | Senza |
| Globus Medical, INC. | $41.96 | 2021 | |
| Zimmer Biomet Holdings, INC. | $41.14 | 2019 | |
| Abbott Laboratories | $36.39 | 2023-2024 | Eterna, Proclaim |
| Integra Lifesciences Corporation | $27.55 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $27.21 | 2019 | |
| Djo, LLC | $22.92 | 2023 | Cmf |
| Boston Scientific Corporation | $21.41 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $17.45 | 2019 | |
| Zyla Life Sciences, INC. | $15.90 | 2019 | |
| Sanara Medtech INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Ragland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.